Lynx1 Capital Management LP - Insider Non-Derivative Transactions at TScan Therapeutics, Inc. (TCRX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 23, 2025, Lynx1 Capital Management LP's relationship to TScan Therapeutics, Inc. (TCRX) is TenPercentOwner, and currently has 8,019,148 shares of Common Stock, and 7,937,416 shares of Common stock, $0.0001 par value per share Common Stock.

The charts below show the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other TCRX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Lynx1 Capital Management LP - Insider Non-Derivative Transactions of TCRX Common Stock

Lynx1 Capital Management LP - Insider Non-Derivative Transactions of TCRX Common stock, $0.0001 par value per share Common Stock

Lynx1 Capital Management LP - Insider Non-Derivative Transactions at TCRX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 24, 2025	P -- (Common Stock)	6232	0.9	8019148
Dec 23, 2025	P -- (Common Stock)	75500	0.9	8012916
Dec 20, 2025	P -- (Common stock, $0.0001 par value per share ("Common Stock"))	80069	0.9	7937416
May 21, 2025	P -- (Common Stock)	1200000	1.2	7946141
May 20, 2025	P -- (Common stock, $0.0001 par value per share ("Common Stock"))	1388794	1.2	6746141
Jun 1, 2023	Sell -- (Common Stock)	400	2.51	5224600
Jun 1, 2023	Sell -- (Common Stock)	15000	2.52	5225000
Jun 1, 2023	Sell -- (Common stock, $0.0001 par value per share Common Stock)	10000	2.51	5240000